Metagenomi stockholders elect Dr. Willard H. Dere as Class I Director and ratify PwC as auditor

Metagenomi Therapeutics, Inc.

Dr. Willard H. Dere elected with 7,580,903 votes for, 2,891,893 withheld, and 8,292,425 broker non-votes.
Ratification of PricewaterhouseCoopers LLP as independent auditor for FY2025: 17,970,776 for, 252,634 against, 541,811 abstentions.
Annual meeting held June 10, 2025; quorum established with 18,765,221 shares present (50.2% of outstanding).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.